Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
WCGC 14
27 - 30 Jun 2012
Gastric cancer in Japan
Dr Takeshi Sano - National Cancer Centre Hospital, Tokyo, Japan
23 Jul 2012
Genetic signatures for colon cancer
Prof Pierre Laurent-Puig - University of Paris, France
23 Jul 2012
An improving outlook for liver cancer patients
Dr Graeme Poston - University Hospital Aintree, Liverpool, UK
23 Jul 2012
Colorectal cancer in the elderly
Dr Demetris Papamichael - BO Cyprus Oncology Centre, Nicosia, Cyprus
23 Jul 2012
The EUREKA Initiative
Prof Cornelius van de Velde - Leiden University Medical Center, Netherlands
23 Jul 2012
Neuroendocrine tumours of the pancreas
Prof Aurel Perren - University of Bern, Switzerland
23 Jul 2012
Prevention best ‘treatment’ for colon cancer
Prof Nadir Arber – Integrated Cancer Prevention Center, Tel Aviv Medical Center,...
20 Jul 2012
Bevacizumab benefits beyond progression in TML study subgroups
Dr Thierry André – Hôpital Saint Antoine, Paris, France
17 Jul 2012
Pharmacodynamic endpoints need to be included in GI trials
Prof Fortunato Ciardiello – Seconda Università degli Studi di Napoli, Italy
17 Jul 2012
Exploring new targets in GI cancer
Prof Josep Tabernero – Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Sp...
17 Jul 2012
Unravelling mechanisms of resistance to targeted drugs
Prof Salvatore Siena – Niguarda Ca’ Granda Hospital, Milan, Italy
17 Jul 2012
CORRECT study data prompts US FDA priority review
Prof Alberto Sobrero – Ospedale San Martino, Genova, Italy
17 Jul 2012
Anti-angiogenic trials; key highlights of the 14th WCGC
Prof Eric Van Cutsem – University Hospital Leuven, Gasthuisberg, Belgium
17 Jul 2012
Perifosine disappoints in refractory mCRC
Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA
16 Jul 2012
Screening and specialist nurses central to patient care
Jola Gore-Booth – EuropaColon, France / UK
16 Jul 2012
Tivantinib first drug to have overall survival benefit as second-line hepatocell...
Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia,...
16 Jul 2012
Adjuvant cetuximab disappoints again in mCRC
Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France
16 Jul 2012
Young Voices United against CRC
Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia
16 Jul 2012
Advances in radiotherapy for rectal cancer
Dr Karin Haustermans – University Hospital Leuven, Belgium
16 Jul 2012
Important to support young medical oncologists’ research
Prof Roberto Labianca – Riuniti Hospital, Bergamo, Italy
16 Jul 2012
